| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 7012 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5377 | 2020 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1176 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 576 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 530 | 2020 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 444 | 2021 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 308 | 2021 |
| Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography F Shakerian, M Hajilooi, B Naghshtabrizi, F Emami Journal of cardiovascular disease research 3 (4), 276-279, 2012 | 31 | 2012 |
| Evaluation of the relationship between serum 25-hydroxy vitamin D and hypertension in hamadan, Iran-A case control study BS NaghShtaBrizi, S Borzouei, PM BigvaNd, MM ali SeifraBiei Journal of Clinical and Diagnostic Research: JCDR 11 (7), LC01, 2017 | 13 | 2017 |
| The association between congenital heart disease and the risk of Autism spectrum disorders or attention-deficit/hyperactivity disorder among children: a meta-analysis E Jenabi, S Bashirian, F Fariba, B Naghshtabrizi The European Journal of Psychiatry 36 (2), 71-76, 2022 | 9 | 2022 |
| Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon N Naghshtabrizi, M Sajedi, B Naghshtabrizi, A Mozayanimonfared, ... Coronary artery disease 31 (6), 527-529, 2020 | 9 | 2020 |
| An evaluation of the numbers and locations of coronary artery disease with some of the major atherosclerotic risk factors in patients with coronary artery disease B Naghshtabrizi, A Moradi, J Amiri, S Aarabi, Z Sanaei Journal of Clinical and Diagnostic Research: JCDR 11 (8), OC21, 2017 | 9 | 2017 |
| Effect of resveratrol supplementation during cardiac rehabilitation exercise training on inflammatory systemic factors in patients undergoing coronary artery bypass surgery … J Almasi, K Azizbeigi, K Mohammad Zade Salamat, B Naghshtabrizi, ... Journal of Gorgan University of Medical Sciences 21 (4), 14-21, 2019 | 7 | 2019 |
| Transient ischemic dilation or transient RV visualization in patients with normal SPECT stress myocardial perfusion imaging: Correlation with CT coronary artery calcium scoring … B Naghshtabrizi, M Alvandi, Z Shaghaghi, SK Hadei, F Fariba, M Moradi, ... Journal of Nuclear Cardiology 29 (5), 2149-2156, 2022 | 6 | 2022 |
| The effect of video-based educational program on satisfaction and comfort in patients undergoing transradial coronary angiography: A single-blinded, randomized controlled trial K Oshvandi, E Movaheditabar, B Naghshtabrizi, Y Mohammadi, ... Journal of Vascular Nursing 39 (2), 27-32, 2021 | 5 | 2021 |
| Comparing clinical outcomes in patients with diabetes undergoing coronary artery bypass graft and percutaneous coronary intervention in real world practice in Iranian population A Arabi, B Naghshtabrizi, HR Baradaran, Y Moradi, M Asadi-Lari, ... BMC cardiovascular disorders 22 (1), 75, 2022 | 4 | 2022 |
| Relationship between severity and complexity of coronary artery involvement and obstructive sleep apnea based on STOP-BANG questionnaire N Naghshtabrizi, S Alizadeh, B Naghshtabrizi, A Jalali, M Salarifar International Journal of Preventive Medicine 13 (1), 34, 2022 | 4 | 2022 |
| Very early discharge of patients with ST-segment-elevation myocardial infarction after primary percutaneous coronary intervention SK Hosseini, B Naghshtabrizi, F Emami, A Yazdi, N Naghshtabrizi, ... The Journal of Tehran University Heart Center 16 (3), 113, 2021 | 3 | 2021 |
| Relation of Neutrophil to Lymphocyte Ratio with Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention F Emami, F Pakrad, J Poorolajal, B Naghshtabrizi, HR Gholalikhani, ... Avicenna Journal of Clinical Medicine 25 (4), 185-192, 2019 | 2 | 2019 |
| Health-related quality of life after percutaneous coronary intervention versus coronary artery bypass graft among iranian patients B Naghshtabrizi, N Matinnia, A Ghaleiha, M Karami Iranian Heart Journal 18 (4), 48-54, 2017 | 2 | 2017 |
